Calendar Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
|
End-of-day quote
Wiener Boerse
2026-10-01
|
5-day change | 1st Jan Change | ||
| 57.65 EUR | -3.11% |
|
-3.27% | -8.93% |
| Jul. 23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| Jul. 23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Chart calendar Laboratorios Farmaceuticos Rovi, S.A.
Upcoming events on Laboratorios Farmaceuticos Rovi, S.A.
| 2026-11-05 | Earnings release - Q3 2026 |
Past events on Laboratorios Farmaceuticos Rovi, S.A.
| 2026-07-23 | Earnings presentation | 04:00 am |
| 2026-07-23 | Earnings release - Q2 2026 | |
| 2026-06-17 | Présentation aux Actionnaires / Analystes | 05:00 am |
| 2026-06-17 | Annual General Meeting | 05:00 am |
| 2026-05-06 | Earnings presentation | 05:00 am |
| 2026-05-06 | Earnings release - Q1 2026 | |
| 2026-02-25 | Earnings presentation | 04:00 am |
| 2026-02-25 | Earnings release - Annual 2025 | |
| 2026-02-23 | Board of Directors Meeting | |
| 2025-11-06 | Earnings release - Q3 2025 |
Past dividends on Laboratorios Farmaceuticos Rovi, S.A.
| 2026-07-13 | Ex-dividend date - 0.77711 EUR | 12:00 am |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 830 823 0.79% | 764 765 -0.15% | 743 731 1.71% | 774 | 892 | 978 |
|
EBITDA Million EUR | Released Forecast Spread | 245 239 2.36% | 207 219 -5.33% | 216 195 10.72% | 198 | 257 | 312 |
|
EBIT Million EUR | Released Forecast Spread | 220 214 2.67% | 179 188 -4.75% | 186 167 11.41% | 164 | 222 | 276 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 220 217 1.8% | 178 195 -8.75% | 183 167 9.91% | 175 | 225 | 275 |
|
Net income Million EUR | Released Forecast Spread | 170 167 2.05% | 137 146 -6.1% | 140 130 7.88% | 146 | 173 | 214 |
|
EPS EUR | Released Forecast Spread | 3,20 3,12 2.58% | 2,67 2,81 -4.87% | 2,75 2,54 8.21% | 2,96 | 3,37 | 4,16 |
| Announcement Date | 27/02/24 | 25/02/25 | 24/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 S1 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 199 194 2.64% | 155 150 3.04% | 160 158 0.78% | 315 310 1.38% | 210 210 0.45% | 218 209 4.59% | 152 153 -0.05% | 192 180 6.58% | 344 331 4.05% |
|
EBITDA Million EUR | Released Forecast Spread | 40,2 38,1 5.58% | 30,3 26,2 15.56% | 35,3 31,8 10.95% | 65,6 61,8 6.15% | 83,9 81,4 3.13% | 66,7 54,6 22.16% | 20,3 21,6 -6.02% | 101 32,8 207.62% | 121 52,3 131.96% |
|
EBIT Million EUR | Released Forecast Spread | 32,8 34,0 -3.42% | 23,0 18,4 24.88% | 27,9 23,8 17.34% | 50,9 47,0 8.51% | 76,3 75,2 1.44% | 58,5 47,8 22.43% | 12,1 13,8 -12.11% | 91,1 23,6 285.98% | 103 36,3 184.36% |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 57,9 53,1 9.12% | ||||||||
|
Net income Million EUR | Released Forecast Spread | 23,4 24,7 -5.21% | 18,1 15,2 18.82% | 21,6 20,0 8.18% | 39,7 38,0 4.57% | 58,0 59,0 -1.65% | 42,7 36,7 16.34% | 9,48 10,4 -8.86% | 75,0 17,9 320.17% | 84,5 27,0 213.45% |
| Announcement Date | 25/02/25 | 08/05/25 | 23/07/25 | 23/07/25 | 06/11/25 | 24/02/26 | 06/05/26 | 23/07/26 | 23/07/26 |
| 2026-10-08 |  | Ex-dividend date - 0.139 CNY | 12:00 am |
| 2026-10-08 | | Sales and Revenue Release - Q3 2026 | 01:00 am |
| 2026-10-09 | | Extraordinary General Meeting | 02:30 am |
| 2026-10-12 | | Earnings presentation | 01:00 am |
| 2026-10-13 | | Earnings presentation | 08:30 am |
| 2026-10-13 | | Earnings release - Q3 2026 | 06:45 am |
| 2026-10-13 | | Extraordinary General Meeting | 02:30 am |
| 2026-10-13 | | Extraordinary General Meeting | |
| 2026-10-14 | | Extraordinary General Meeting | |
| 2026-10-14 | | Ex-dividend date - 1.02 CNY | 12:00 am |
Past sector events for Laboratorios Farmaceuticos Rovi, S.A.
| 2026-10-02 | | Ex-dividend date - 0.63 USD | 12:00 am |
| 2026-10-02 | | Analyst/Investor Day | 01:00 am |
| 2026-10-01 | | Information meeting | 08:00 am |
| 2026-10-01 | | Board of Directors Meeting | 05:30 am |
| 2026-10-01 | | Ex-dividend date - 0.99186 INR | 12:00 am |
| 2026-10-01 | | Ex-dividend date - 0.99186 INR | 12:00 am |
| 2026-09-30 | | Information meeting | |
| 2026-09-30 | | Annual General Meeting | 01:30 am |
| 2026-09-30 | | Présentation aux Actionnaires / Analystes | 01:30 am |
| 2026-09-30 | | Extraordinary General Meeting | 02:30 am |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
- ROVI Stock
- Calendar Laboratorios Farmaceuticos Rovi, S.A.
Select your edition
All financial news and data tailored to specific country editions
